Related Experiment Video
Updated: Jun 14, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Bidirectional association of rheumatoid arthritis and inflammatory bowel diseases: a large-scale prospective cohort
Yijun Chen1, Qian Zhang1, Si Liu1
1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; State Key Laboratory of Digestive Health; National Clinical Research Center for Digestive Diseases; Beijing Key Laboratory of Early Gastrointestinal Cancer Medicine and Medical Devices, Beijing, China.
Objectives:
To investigate the bidirectional prospective association between inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) in a large-scale, long-term follow-up, population-based cohort.
Methods:
Participants free of any cancer at baseline were included and divided into two prospective cohorts: baseline IBD and incident RA (cohort 1), and baseline RA and incident IBD (cohort 2). The primary outcome was incident RA in cohort 1 and incident IBD, including ulcerative colitis (UC) and Crohn's disease (CD), in cohort 2, separately. Cox proportional hazard regression models were used to investigate the bidirectional relationship between RA and IBD.
Results:
Overall, 449 662 and 450 534 participants were included in cohort 1 and cohort 2, respectively, with 5015 prevalent IBD and 5887 prevalent RA cases at baseline, respectively. During a median of 14.3- and 14.6-year follow-up, 6001 (1.3%) cases of RA and 2988 (0.7%) cases of IBD were identified in cohort 1 and 2, respectively. Compared with non-IBD, IBD patients (hazard ratio [HR] = 1.44; 95% CI: 1.15, 1.79) showed a significantly higher risk of incident RA, particularly in UC patients (HR = 1.36; 95% CI: 1.06, 1.75) after multivariable adjustment. Similarly, RA patients had a 1.65-fold higher risk (95% CI: 1.31, 2.09) of incident IBD, with a 60% and 65% excess risk of developing UC (HR = 1.60; 95% CI: 1.20, 2.13) and CD (HR = 1.65; 95% CI: 1.12, 2.42), respectively. Further sensitivity analysis and subgroup analysis indicated similar results.
Conclusion:
IBD is associated with an increased risk of RA, and vice versa. Further studies are warranted to confirm the findings and elucidate the underlying biological mechanisms.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

